Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Clinic Secret vs Hims & Hers

Clinic Secret
Graded #301

Lower grade

vs+19.9
Hims & Hers
Graded #36

Higher grade

The verdict

Hims & Hers takes it — 81/100 to 61.1/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +27
55
82
Dose & formulationHims & Hers +14
64
78
Clinical oversightHims & Hers +8
74
82
Labs & monitoringHims & Hers +28
52
80
FulfillmentHims & Hers +25
59
84
Contract termsHims & Hers +19
61
80
Clinic Secret · left barHims & Hers · right bar

The numbers

MetricClinic SecretHims & Hers
WeighScore61.1/10081/100
GradeCB−
Scorecard rank#301#36
Semaglutide$196/mo (starting dose, compounded)$199/mo
Tirzepatide$196/mo (compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Clinic Secret

Graded #301 · C

Strengths

  • Low entry price starting at $49/week with no membership fees
  • Monthly price does not increase as dosage rises
  • Fast nationwide shipping in about three days
  • Asynchronous intake available in some states (no required video call)
  • Money-back guarantee tied to weight-loss goals

Where it loses points

  • Newly launched (late 2025); limited independent track record
  • Compounded medications only; no FDA-approved brand options
  • Named compounding pharmacy not disclosed
  • State availability not published
  • No insurance accepted
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard